Skip to main content

Support WBUR

FDA Approves Marketing Of Consumer Genetic Tests For Some Conditions

23andMe is now allowed to market tests that assess genetic risks for 10 health conditions, including Parkinson's and late-onset Alzheimer's diseases. (Meredith Rizzo/NPR)
23andMe is now allowed to market tests that assess genetic risks for 10 health conditions, including Parkinson's and late-onset Alzheimer's diseases. (Meredith Rizzo/NPR)

Related:

Support WBUR

Support WBUR

Listen Live